Rare metabolic diseases among the Irish travellers: results from the All Ireland Traveller Health Study census and birth cohort (2007-2011)
Abstract
Keywords
Full Text:
PDFReferences
Jinnah HA. Needles in haystacks: the challenges of rare diseases. Developmental Medicine and Child Neurology. 2011 Jan;53(1):6-7.
Day S. Evidence-Based Medicine and Rare Diseases. Rare Diseases Epidemiology 2010:41-53.
Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. The Lancet 2008;371(9629):2039-41.
Pampols T. Inherited Metabolic Rare Disease. Rare Diseases Epidemiology 2010;686(5):397-431.
Groft SC, Paz MP. Rare Diseases–Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data. Rare Diseases Epidemiology 2010:3-14.
RD-Connect (EU). About RD-Connect. 2014 [updated 2014; cited 20 January 2014] Available from: http://rd-connect.eu/ about
National Institutes of Health (US). Global Rare Disease Patient Registry And Data Repository. 2014 [Updated 2014; cited 20 January 2014] Available from: http://rarediseases.info.nih.gov/research/pages/43/global-rare-disease-patient-registry-and-data-repository
Equality Authority. Traveller ethnicity: an Equality Authority Report. Dublin: Brunswick Press Ltd, 2006.
All Ireland Traveller Health Study Team. Technical Report 1: Health Survey Findings. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: Department of Health and Children, 2010.
Hamid N, Daly L, Fitzpatrick P. Technical Report 2D: The Birth Cohort Follow Up. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: University College Dublin, 2011.
Paz MP, Villaverde-Hueso A, Alonso V, János S, Zurriaga Ó, Pollán M, et al. Rare Diseases Epidemiology Research. Rare Diseases Epidemiology 2010:17-39.
Murphy AM, Lambert D, Treacy EP, O'Meara A, Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic. Archives of Disease in Childhood. 2009;94(1):52-4.
Murphy M, McHugh B, Tighe O, Mayne P, O'Neill C, Naughten E, et al. Genetic basis of transferase-deficient galactosaemia in ireland and the population history of the irish travellers. European Journal of Human Genetics. 1999;7(5):549-54.
Barry J, Daly L. The Travellers' Health Status Study: Census of Travelling People, November 1986. Dublin: The Health Research Board, 1988.
Coss KP, Doran PP, Owoeye C, Codd MB, Hamid N, Mayne PD, et al. Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment. Journal of Inherited Metabolic Disease. 2013;36(1):21-7.
Hamid N, Turner J, Abdalla S, Quirke B, Daly L, Fitzpatrick P. Technical Report 2B: The Birth Cohort Study. In: Kelleher C, editor. All Ireland Traveller Health Study. Dublin: Department of Health and Children, 2010.
Orphanet. Prevalence of rare diseases: Bibliographic data. Orphanet Report Series. France, 2012.
Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet Journal of Rare Diseases. 2008;3.
Murphy AM, Lambert D, Treacy EP, O'Meara A, Lynch SA. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic. Archives of Disease in Childhood. 2009;94(1):52-4
Malm G, Lund AM, Månsson JE, Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Pædiatrica 2008;97(11):1577-81.
Badawi N, Cahalane SF, McDonald M, Mulhair P, Begi B, Odonohue A, et al. Galactosaemia - A controversial disorder. Screening & outcome. Ireland 1972-1992. Irish Medical Journal. 1996;89(1):16-7.
Barry J, Herity B, Solan J. The Travellers' Health Status Study: Vital Statistics of Travelling People 1987. Dublin: The Health Research Board, 1989.
Orioli I, Castilla E, Barbosa-Neto J. The birth prevalence rates for the skeletal dysplasias. Journal of Medical Genetics. 1986;23(4):328.
Andersen PE, Hauge M. Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clinical Genetics. 1989;36(4):250-5.
Martin E, Shapiro JR. Osteogenesis imperfecta: epidemiology and pathophysiology. Current Osteoporosis Reports 2007;5(3):91-97.
McElligot F, Beatty E, O'Sullivan S, Hughes J, Lambert D, Cooper A, et al. Incidence of I-Cell disease (mucolipidosis type II) in the Irish population. Journal of Inherited Metabolic Disease. 2011;34(suppl 3):S206.
Coutinho M, Encarnacao M, Gomes R, Da Silva Santos L, Martins S, Sirois-Gagnon D, et al. Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity. Clinical Genetics 2011;(80):273-280.
Barry J, Kirke P. Congenital anomalies in the Irish traveller community. Irish Medical Journal. 1997;90(6):233-4.
Drummond A. Irish Travellers and the Criminal Justics Systems across the Island of Ireland. University of Ulster, 2010.
McDonagh M. Nomadism in Irish Travellers’ Identity. In: McCann M, O Siochain S, Ruane J, editors. Irish Travellers: Culture and ethnicity. Belfast: Institute of Irish Studies, 1994:30-66.
Jones S. In the blood: Gods, genes and destiny. Hammersmith: Flamingo, 1997.
Bittles AH. THE ROLE AND SIGNIFICANCE OF CONSANGUINITY AS A DEMOGRAPHIC VARIABLE. Population and Development Review. 1994;20(3):561-84.
Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006;333(7573):831-34.
Darr A. Access to Genetic Services by Minority Ethnic Populations. A Pilot 1999.
Zlotogora J, Carmi R, Lev B, Shalev SA. A targeted population carrier screening program for severe and frequent genetic diseases in Israel. European. Journal of Human Genetics. 2008;17(5):591-97.
Rosner G, Rosner S, Orr-Urtreger A. Genetic testing in Israel: an overview. Annual Review of Genomics and Human Genetics 2009;10:175-92.
McGorrian C, Shortt E, Doyle O, Kelleher C. Breastfeeding is natural, but it’s not the norm in Ireland, Dublin: Department of Health and Children, 2010.
National Newborn Screening Programme Working Group. Review of the national Screening Programme for Inherited Metabolic Disorders. Dublin: Health Service Executive, 2004.